White Paper

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify

Polaris Quantum Biotech (PolarisQB) leverages quantum computing to accelerate drug discovery, revolutionizing

At Polaris Quantum Biotech, we’re leveraging quantum computing to accelerate drug discovery.

The scientists at POLARISqb designed and engineered the first drug discovery engine built